December 13, 2024 02:45 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
Oxford COVID-19 vaccine is safe and protects against disease, shows first published results from phase 3 trials

Oxford COVID-19 vaccine is safe and protects against disease, shows first published results from phase 3 trials

Dec 10, 2020, at 12:16 am

London: Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases – with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half then a full dose (both trial arms pre-specified in the pooled analysis). 

COVID-19: Oxford vaccine shows 70 percent efficiency 

COVID-19: Oxford vaccine shows 70 percent efficiency 

Nov 23, 2020, at 08:31 pm

London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said.